Forecasting the Biological Effect of PEGylated-rHuEPO Candidates in Chronic Kidney Disease Patients using a Middle-out Translation Approach

Pharmaceutical Research 2026

View at publisher
Authors: Gledys Reynaldo Fernández, Leyanis Rodríguez‐Vera, Daniel Amaro‐González, J Solozabal, Jorge Duconge-Soler, Victor Mangas Sanjuan, Iñaki Troconiz, Francine Johansson Azeredo, Valvanera Vozmediano
DOI: 10.1007/s11095-025-04013-z
Cited by: 0
References: 37

Fields of Study & Subjects

Erythropoietin and Anemia Treatment Biosimilars and Bioanalytical Methods Pharmaceutical studies and practices

Publication details

Journal / source
Pharmaceutical Research
Volume
43
Issue
2
Pages
381–393
Publication date
15 January 2026
Language
EN